Cargando…

Editorial: Disease modifying therapies in multiple sclerosis

Detalles Bibliográficos
Autores principales:	Bonavita, Simona, Ghajarzadeh, Mahsa, Lavorgna, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442044/ https://www.ncbi.nlm.nih.gov/pubmed/36071892 http://dx.doi.org/10.3389/fneur.2022.927321

Ejemplares similares

Family Planning Decision Making in People With Multiple Sclerosis
por: Bonavita, Simona, et al.
Publicado: (2021)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study †
por: Miele, Giuseppina, et al.
Publicado: (2023)

The Role of Wearable Devices in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2018)

Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS)
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2022)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
por: Simone, Isabella Laura, et al.
Publicado: (2021)

Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022)

Editorial: Preventing multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2022)

Editorial: Cognition in Multiple Sclerosis
por: Cortese, Rosa, et al.
Publicado: (2021)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
por: Simoens, Steven
Publicado: (2022)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series
por: Abbadessa, Gianmarco, et al.
Publicado: (2022)

Editorial: Digital Technology in Neurology: From Clinical Assessment to Neurorehabilitation
por: Moccia, Marcello, et al.
Publicado: (2021)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Editorial: Corticospinal Excitability in Patients With Multiple Sclerosis
por: Chalah, Moussa A., et al.
Publicado: (2021)

Editorial: Insights in multiple sclerosis and neuroimmunology: 2021
por: Weissert, Robert
Publicado: (2023)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
por: Claflin, Suzi B., et al.
Publicado: (2019)

Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?
por: Martin, Sarah-Jane, et al.
Publicado: (2023)

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
por: Zanghì, Aurora, et al.
Publicado: (2022)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

Editorial: Fatigue in multiple sclerosis—A current perspective
por: Pokryszko-Dragan, Anna, et al.
Publicado: (2023)

Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies
por: Bridge, Francesca, et al.
Publicado: (2023)

The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
por: Kania, Karolina, et al.
Publicado: (2023)

Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
por: Capone, Fioravante, et al.
Publicado: (2022)

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
por: Vollmer, Brandi L., et al.
Publicado: (2022)

Editorial: Multiple Sclerosis and Neuroimmunology—Case Report Collection, Volume I
por: Weissert, Robert
Publicado: (2022)

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study
por: Al-Sakran, Lina, et al.
Publicado: (2019)

Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study
por: Arroyo, Rafael, et al.
Publicado: (2017)

Editorial: Women in multiple sclerosis and other demyelinating disorders: A global perspective
por: Ciampi, Ethel, et al.
Publicado: (2023)

Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Characteristics of COVID-19 disease in multiple sclerosis patients
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
por: Lees, Samuel, et al.
Publicado: (2021)

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8upcdg9jnkgasm37485et3etuj